HPV vaccine prevents CIN in wider age range

The protective effect of HPV vaccination is now being seen among women in their mid twenties, in whom the rate of high grade cervical abnormalities has almost halved since 2007, Victorian figures show.

In the seven years since the HPV vaccination program was introduced, rates of high grade cervical intra-epithelial neoplasia/carcinoma in situ (CIN) declined from 21.5 to 13.5 per 1000 screened women in the 20-24-year age group, according to figures released by the Victorian Cytology